Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT06438705
Eligibility Criteria:
Inclusion Criteria:
* Voluntary subjects, patients or their legal representatives sign informed consent;
* Volunteers are of any gender and aged between 18 and 75 years old, including the cut-off value;
* Other imaging methods found tumor occupying;
* Patients with pre-treatment tumors for whom surgery or biopsy may be performed to obtain final pathological results.
* Kidney glomerular filtration rate(GFR)\>50 ml/min, effective renal plasma flow(ERPF)\>280 ml/min, platelet count (PLT) \>75 000/μL, white blood cell (WBC) \>3000/μL, alanine aminotransferase ALT, aspartate aminotransferase AST less than 3 times the normal value.
Exclusion Criteria:
* People who have a history of allergy to similar drugs , allergic constitution or are currently suffering from allergic diseases;
* Is conducting clinical research on other drugs, or has participated in clinical research on any drugs (excluding vitamins and minerals);
* Have other clinical problems that are difficult to control (such as hepatitis C virus infection or active hepatitis B, or other serious chronic infections and serious mental, neurological, cardiovascular, respiratory and other diseases);
* Obvious abnormal liver and kidney function, GFR less than 50 ml/min;
* Tumor load is greater than 50%, or there is obvious spinal cord compression;
* The expected survival period is less than half a year; Chemotherapy was performed within 6 months.
* Have severe acute concomitant diseases or serious refractory mental disorders;
* Pregnant and lactating women (where pregnancy is defined as a positive urine pregnancy study);
* Patients whose physical condition is not suitable for radiological examination;
* Other situations deemed inappropriate by the investigator to participate in the trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06438705
Study Brief:
Protocol Section:
NCT06438705